Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy

被引：0
|
作者：
Bone, H. G. [1 ]
Ellis, G. [2 ]
Yuen, C. K. [3 ]
Kendler, D. L. [4 ]
Fan, M. [5 ]
Wang, H. [5 ]
Kim, D. [5 ]
Liu, Y. [5 ]
Dansey, R. [5 ]
Martin, J. San [5 ]
机构：
[1] Michigan Bone & Mineral Clin, Detroit, MI USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Catherine Van Poznak
    Breast Cancer Research, 12
  • [22] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Van Poznak, Catherine
    BREAST CANCER RESEARCH, 2010, 12 (03):
  • [23] CHANGES IN BONE DENSITY OVER 1 YEAR OF AROMATASE INHIBITOR THERAPY IN WOMEN WITH POSTMENOPAUSAL BREAST CANCER AND OSTEOPENIA
    Taxel, Pamela
    Bansal, Renu
    Mirza, Faryal
    Hawli, Yousra
    Tannenbaum, Susan
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S220 - S220
  • [24] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Ouchi, Yoshimi
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Taguchi, Tetsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (02) : 301 - 306
  • [25] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Ouchi
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Tetsuya Taguchi
    Journal of Bone and Mineral Metabolism, 2019, 37 : 301 - 306
  • [26] DENOSUMAB DECREASES CORTICAL POROSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Zebaze, R. M.
    Boyd, S. K.
    Nishiyama, K. K.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, T.
    Boutroy, S.
    Bogado, C.
    Austin, M.
    Libanati, C.
    Seeman, E.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S527 - S527
  • [27] Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density
    Libanati, C.
    Boyd, S. K.
    Nishiyama, K. K.
    Zebaze, R. M.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, Thierry
    Boutroy, S.
    Bogado, C. E.
    Austin, M.
    Seeman, E.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S637 - S638
  • [28] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Tsaaareli, M.
    Giorgadze, E.
    Khachidze, N.
    Sharilcadze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S268 - S269
  • [29] The change of bone mineral density during aromatase inhibitor therapy alone and combining zoledronic acid in postmenopausal Korean breast cancer patients
    Lee, S. A.
    Jeong, J.
    Hwang, S. H.
    Lee, H. D.
    EJC SUPPLEMENTS, 2010, 8 (03): : 164 - 164
  • [30] Effect of denosumab on low bone mineral density in postmenopausal Japanese early breast cancer patients receiving aromatase nhibitors: 36-month results
    Sakaguchi, K.
    Nakatsukasa, K.
    Koyama, H.
    Matsuda, T.
    Kato, M.
    Ouchi, Y.
    Morita, M.
    Taguchi, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 69 - 69
12345